Co-Founder, Unique LabsRajshahi, Bangladesh

Shahriar Ahmed

Researcher, Biochemist, Cancer Biology Researcher, Founder, Developer, Technology Enthusiast

Exploring the intersection of molecular biology, cancer research, computational tools, entrepreneurship, and emerging technology.

Portrait of Shahriar Ahmed, Co-Founder of Unique Labs
Shahriar AhmedBiochemistry & Molecular Biology
  • Cancer biology
  • Molecular biology techniques
  • Computational tools
  • AI & automation
  • Entrepreneurship
  • KOC & Consultancy
  • Digital Marketing
  • Blockchain Development
  • Molecular Biology
  • Cell Culture
  • SDS-PAGE
  • Affinity Chromatography
  • Hemagglutination Assay
  • MTT Assay
  • qPCR
  • Apoptosis Analysis
  • Python
  • JavaScript
  • TypeScript
  • HTML
  • CSS
  • Next.js
  • Git
  • APIs
  • Automation
  • Smart Contracts
  • EVM Chains
  • dApp Development
  • Web3 Incubation
  • Payment Integration
  • Tokenomics

01About

About Me

I am a Biochemistry & Molecular Biology researcher interested in understanding molecular mechanisms underlying disease and exploring how modern computational technologies can accelerate scientific discovery.

  • Field

    Biochemistry & Molecular Biology

  • Master’s student

    University of Rajshahi

  • Co-Founder

    Unique Labs

  • Based in

    Rajshahi, Bangladesh

02Work

Research, ventures & products

What I am working on — each links to more.

All projects

03Publications

Publications

Published scientific work

01Published paper

  1. 01

    Published

    Journal of Molecular Structure

    Solvent-dependent nonlinear optical response and potential Mcl-1 antagonist activity of an azo–hydrazone derivative: Experimental and theoretical studies

    Authors: Md. Abdur Rakib, Billal Hossain, Jenia Afrin Tanni, Md. Shohag Hossain, Md. Shakirul Hasan Sium, Shahriar Ahmed Tushar, Md. Tanvir Anjum, Shofiur Rahman, M. Shahed Zaman, Md. Badrul Islam, Md. Rabiul Karim

    Journal
    Journal of Molecular Structure
    Published
    Presented at
    2nd International Conference on “Recent Advances in Science and Technology” (ICRAST)
    Read the abstract

    An azo-hydrazone derivative, 4-((E)-phenyldiazenyl)-2-((E)-(2-phenylhydrazono)methyl)phenol (PDPMP), was synthesized and characterized using FT-IR, UV–Vis, NMR, and LC-MS. Its structural, electronic, and nonlinear optical (NLO) properties were examined via DFT and TD-DFT at the B3LYP/6–311++G(d,p) level with the IEFPCM solvent model. The influence of solvent polarity on electronic transitions, charge transfer, NLO response, and antagonist activity was explored systematically. Solvent polarity significantly altered UV–Vis absorption, HOMO–LUMO gap, charge-transfer behavior, and NLO efficiency. PDPMP exhibited first-order hyperpolarizability (βtotal) of 537 × 10⁻³¹ esu, which is approximately 69 times greater than the reference value for urea (βtotal = 7.803 × 10⁻³¹ esu) and 3.5 time than p-nitroaniline (βtotal = 155 × 10–31 esu) and increasing up to threefold in polar solvents with notable positive solvatochromism. NTO and TDM analyses confirmed solvent-induced intramolecular charge transfer, while NBO and RDG analyses revealed orbital delocalization and noncovalent interactions. Molecular docking against Mcl-1 (PDB IDs: 4HW3, 6GL8) suggested that PDPMP has higher binding affinity than the preclinical drug Obatoclax. These findings suggest that it may serve as a dual-function NLO material and merit additional investigation for its potential as an anticancer agent.

04Contact

Let’s Connect

For research collaborations, technology projects, entrepreneurship, or interesting ideas, feel free to reach out.

shahriar.bmb@gmail.com